<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>行舟Drug | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2021-01-12T02:19:37+08:00</updated>
  <subtitle>It takes nothing to join the crowd, but it takes everything to stand alone</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>收藏 | 26种仪器分析的原理及谱图方法大全</title>
    <updated>2021-01-11T19:33:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-11:/s/t-SAM-ylAjbnuCqIsjqN4w</id>
    <link href="https://mp.weixin.qq.com/s/t-SAM-ylAjbnuCqIsjqN4w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>如何解读ICH指导原则中的杂质三限（报告限，鉴定限，界定限）</title>
    <updated>2021-01-11T19:33:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-11:/s/SmhuN9Vty6APiWwYygDNtg</id>
    <link href="https://mp.weixin.qq.com/s/SmhuN9Vty6APiWwYygDNtg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>创新药IND申报流程事宜图</title>
    <updated>2021-01-11T19:33:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-11:/s/Br9yySsUvGmsJw9SJiw9ow</id>
    <link href="https://mp.weixin.qq.com/s/Br9yySsUvGmsJw9SJiw9ow" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>器审中心 2020全年答疑汇总</title>
    <updated>2021-01-11T19:33:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-11:/s/VBlsCdhlpc4LJBsb1Y0XFw</id>
    <link href="https://mp.weixin.qq.com/s/VBlsCdhlpc4LJBsb1Y0XFw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>严重副作用不同疾病的对应手册（面向患者·公众）（52）-肺水肿</title>
    <updated>2021-01-10T19:42:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-10:/s/dRiWrdMYad8AnLOUh6Yrmw</id>
    <link href="https://mp.weixin.qq.com/s/dRiWrdMYad8AnLOUh6Yrmw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>请回答2020：中国创新药“后浪养成记”之新药研发交易篇</title>
    <updated>2021-01-10T19:42:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-10:/s/BH9na6NXlQJvXmjOtPQEXg</id>
    <link href="https://mp.weixin.qq.com/s/BH9na6NXlQJvXmjOtPQEXg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>CFDI｜研发阶段的记录要求</title>
    <updated>2021-01-09T20:34:19+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-09:/s/wPQhDKZHY3M13ZN-tmOfLw</id>
    <link href="https://mp.weixin.qq.com/s/wPQhDKZHY3M13ZN-tmOfLw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>恒瑞阿帕替尼肝癌适应症获批，未进临床路径药品或面临淘汰，三级医院将进行分类管理……</title>
    <updated>2021-01-09T20:34:19+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-09:/s/N_wQh3yVDKFtXixde2ztfA</id>
    <link href="https://mp.weixin.qq.com/s/N_wQh3yVDKFtXixde2ztfA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>62家药企宣布退市（附名单）</title>
    <updated>2021-01-09T20:34:19+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-09:/s/9ZcvHQFVNbuWktGuHrQV2A</id>
    <link href="https://mp.weixin.qq.com/s/9ZcvHQFVNbuWktGuHrQV2A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>专家文章｜生物类似药的研究进展及挑战</title>
    <updated>2021-01-08T20:42:38+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-08:/s/1J0O9g_aeESr2bLn_mNX7A</id>
    <link href="https://mp.weixin.qq.com/s/1J0O9g_aeESr2bLn_mNX7A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>这些重磅医药政策2021年开始实行！</title>
    <updated>2021-01-08T20:42:38+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-08:/s/A4U8cHphOV1Sley1hEcZUQ</id>
    <link href="https://mp.weixin.qq.com/s/A4U8cHphOV1Sley1hEcZUQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>TIL免疫细胞疗法：击退肿瘤重燃生的希望！</title>
    <updated>2021-01-08T20:42:38+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-08:/s/3G4yXBnWJw_sSr1-9Du-Aw</id>
    <link href="https://mp.weixin.qq.com/s/3G4yXBnWJw_sSr1-9Du-Aw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>专家文章｜我国药品上市许可持有人药物警戒职责分析</title>
    <updated>2021-01-07T20:19:38+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-07:/s/Enl81ZL0uVDr9tVXmllkXA</id>
    <link href="https://mp.weixin.qq.com/s/Enl81ZL0uVDr9tVXmllkXA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>全球新冠疫苗技术路线和研究靶点</title>
    <updated>2021-01-07T20:19:38+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-07:/s/gaZ4aquzXL6epggIgpwyIg</id>
    <link href="https://mp.weixin.qq.com/s/gaZ4aquzXL6epggIgpwyIg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>审评专家万字长文详细解读研究原始记录的常见问题</title>
    <updated>2021-01-06T20:04:35+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-06:/s/pYvTY8Fxw9fQwaiCA3p7uA</id>
    <link href="https://mp.weixin.qq.com/s/pYvTY8Fxw9fQwaiCA3p7uA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>全线治疗创新, 奥希替尼成为EGFR突变肺癌病人的优选靶向药</title>
    <updated>2021-01-06T20:04:35+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-06:/s/Ghl7Qw4tWstwUrhZzvq3fQ</id>
    <link href="https://mp.weixin.qq.com/s/Ghl7Qw4tWstwUrhZzvq3fQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>直击中国新冠灭活疫苗生产现场！</title>
    <updated>2021-01-05T19:41:05+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-05:/s/x7Y75G6Eh41FpYf8r2IOeg</id>
    <link href="https://mp.weixin.qq.com/s/x7Y75G6Eh41FpYf8r2IOeg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>生物仿制药可比性研究面临的挑战</title>
    <updated>2021-01-05T19:41:05+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-05:/s/swqiei-RpYvZ6dQYnbUC7g</id>
    <link href="https://mp.weixin.qq.com/s/swqiei-RpYvZ6dQYnbUC7g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>科普 | 一图了解新冠疫苗接种</title>
    <updated>2021-01-05T19:41:05+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-05:/s/y9Rke1RlrQl2PHANCNZWuw</id>
    <link href="https://mp.weixin.qq.com/s/y9Rke1RlrQl2PHANCNZWuw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020年FDA批准的这十大新药，销售峰值有望达160亿美元！</title>
    <updated>2021-01-05T19:41:05+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-05:/s/mD762ytIqz_7MRXIuOMwIg</id>
    <link href="https://mp.weixin.qq.com/s/mD762ytIqz_7MRXIuOMwIg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>